The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries.
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm, Extent IV Thoracoabdominal, Pararenal Aneurysm
The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries.
Zenith® Fenestrated+ Clinical Study
-
University of Alabama Birmingham Hospital, Birmingham, Alabama, United States, 35294
UC San Diego, La Jolla, California, United States, 92037
University of Southern California, Los Angeles, California, United States, 90031
Stanford Hospitals and Clinics, Stanford, California, United States, 94305
Medstar Washington Hospital Center, Washington, District of Columbia, United States, 20010
University of Florida Shands Hospital, Gainesville, Florida, United States, 32610
Tampa General Hospital, Tampa, Florida, United States, 33606
Emory University Hospital, Atlanta, Georgia, United States, 30322
Northwestern Memorial Hospital, Chicago, Illinois, United States, 60611
Loyola University Medical Center, Maywood, Illinois, United States, 60153
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Cook Research Incorporated,
Gustavo Oderich, MD, PRINCIPAL_INVESTIGATOR, Memorial Hermann Texas Medical Center
2031-04